Saturday, August 9, 2014

Top High Tech Stocks To Own For 2014

  Wal-Mart defends Thanksgiving opening NEW YORK (CNNMoney) Wal-Mart opened its stores at 6 p.m. this year, two hours earlier than last year and smack in the middle of most families' Thanksgiving dinners. So what does one of its top executives have to say?

CNNMoney spoke with Wal-Mart's (WMT, Fortune 500) U.S. CEO Bill Simon.

Is shopping the kind of family tradition Wal-Mart wants to perpetuate?

Simon: Our job is to try to anticipate what the customer wants... Having families out, children in the building... gives it a different feel. And it's one that's in line with who we are at Wal-Mart. It feels a lot better in the evening than it did when it was early in the morning [on Black Friday].

Hot Communications Equipment Stocks To Buy For 2015: FreeSeas Inc.(FREE)

FreeSeas Inc., through its subsidiaries, operates as a bulk transportation company. The company transports various drybulk commodities, including iron ore, grain, and coal, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar, rice, and minor bulks. As of December 31, 2010, it owned and operated nine vessels, including seven Handysize and two Handymax dry bulk carriers. The company was formerly known as Adventure Holdings S.A. and changed its name to FreeSeas Inc. in April 2005. FreeSeas Inc. was incorporated in 2004 and is based in Piraeus, Greece.

Advisors' Opinion:
  • [By Rebecca McClay]

    And dry bulk shippers like FreeSeas Inc. (Nasdaq: FREE), Seanergy Maritime Holdings Corp. (Nasdaq: SHIP), and Eagle Bulk Shipping Inc. (Nasdaq: EGLE) are noting big gains today as shipping rates strengthen. FREE is up 8%, SHIP is up 13%, and EGLE is up 7% as capesize shipping rates increased overnight by about 10%, exceeding $20,000 for the first time since January 2012.

  • [By Bryan Murphy]

    September is on pace to be a banner month for shipping stocks FreeSeas Inc. (NASDAQ:FREE), DryShips Inc. (NASDAQ:DRYS), and Eagle Bulk Shipping Inc. (NASDAQ:EGLE). They're up 290%, 62%, and 115%, respectively, month-to-date, overcoming an amazingly long dry spell. The question is, why have EGLE, FREE, and DRYS been so strong all of a sudden, and more than that, are these rallies built to last?

  • [By Bryan Murphy]

    The last few weeks have been, shall we say "interesting" for maritime shipping stocks like FreeSeas Inc. (NASDAQ:FREE), DryShips Inc. (NASDAQ:DRYS), and NewLead Holdings Ltd (NASDAQ:NEWL). The strong rise in the Baltic Dry Index - the average daily charter rate of a dry goods vessel - since mid-August (and really since early June) has meant maritime shippers can charge more for their services, and who knows? Maybe they can even turn a profit sometime in the foreseeable future. As a result of that possibility, DRYS gained nearly 100% in a little over a month., NEWL was up as much as 70% at one point in late September, and FREE advanced nearly 300% on the heels of the Baltic Dry Index's runup from 1000 to more than 2000 in just a little over a month.

  • [By James E. Brumley]

    Back in early November, yours truly penned some bullish thoughts on FreeSeas Inc. (NASDAQ:FREE), NewLead Holdings Ltd (NASDAQ:NEWL), and DryShips Inc. (NASDAQ:DRYS). While each stock has its own merits, the crux of the bullishness was ultimately rooted in the brewing rebound of the Baltic Dry Index... a reflection of the prices companies pay shippers like FreeSeas and DryShips to haul goods over the ocean.

Top High Tech Stocks To Own For 2014: Seattle Genetics Inc.(SGEN)

Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The company?s other product candidates in various stages of clinical trials include SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; dacetuzumab (SGN-40), a humanized anti-CD40 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc .; Daiichi Sankyo Co., Ltd.; Genentech, Inc.; GlaxoSmithKline LLC; Millennium; and PSMA Development Company LLC. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc.; and Genmab A/S. Seattle Genetics, Inc. was founded in 1997 and is headquartered in Bothell, Washington.

Advisors' Opinion:
  • [By Lee Jackson]

    While very upbeat on the sector as a whole, UBS was very cautious on sell-rated Ironwood Pharmaceuticals, Inc (NASDAQ: IRWD) and ImmunoGen Inc. (NASDAQ: IMGN). Neutral-rated Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Seattle Genetics Inc. (NASDAQ: SGEN) were also viewed with a skeptical eye.

  • [By Brian Orelli]

    It's certainly in the FDA's right to ask outside experts for their opinion; I would argue it's not all that surprising even if the FDA is leaning strongly toward approving the drug. There are plenty of cases --�Seattle Genetics' (NASDAQ: SGEN  ) Adcetris,�for example�--�where the FDA called a meeting only to gush all over the drug. The drug got a unanimous positive recommendation from the panel and was approved early by the FDA.

  • [By Sean Williams]

    These might not be household names in the U.S., but they do brandish global licensing partnerships with companies that might be more familiar to you. Takeda, for example, has licensing agreements in place with Orexigen Therapeutics (NASDAQ: OREX  ) , which recently filed a New Drug Application for its chronic weight management (i.e., anti-obesity) pill, Contrave, in the U.S. Takeda owns the right to Contrave outside of North America. In addition, Takeda is a collaborative partner of antibody-drug conjugate developer Seattle Genetics (NASDAQ: SGEN  ) with regard to FDA-approved Hodgkin lymphoma drug Adcetris.�

Top High Tech Stocks To Own For 2014: AKB Mosoblbank OAO (MOBB)

AKB MOSOBLBANK OAO (AKB MOSOBLBANK OJSC) is a Russia-based commercial bank. The Company focuses on the provision of various types of banking services to both individual and corporate clients. The Bank offers its services through the network of 400 offices and automated teller machines (ATM), located across the Russian Federation. In addition, it has 23 branches in such cities as: Rostov na Donu, Samara, Astrakhan, Arkhangelsk, Nizhny Novgorod, Omsk, Tyumen, Yakutsk, Grozny, Kemerovo and Vladivostok, among others. As of May 25, 2012, the Company�� major shareholder was Respublikanskaya Finansovaya Korporatsiya OAO with a stake of 74.19%. Advisors' Opinion:
  • [By Corinne Gretler]

    UBS, Switzerland�� largest bank, rallied to a two-year high. Philips, the Dutch maker of light bulbs and electric toothbrushes, gained for an eighth day. Portugal�� PSI-20 Index (PSI20) advanced 2.3 percent as President Anibal Cavaco Silva affirmed that he doesn�� want to call early elections. Mobistar (MOBB) SA slumped the most on record after the Belgian mobile-phone company cut profit forecasts and suspended its dividend.

Top High Tech Stocks To Own For 2014: Synnex Corporation(SNX)

SYNNEX Corporation provides distribution and business process outsourcing (BPO) services to resellers, retailers, and original equipment manufacturers (OEMs) worldwide. The company operates in two segments, Distribution Services and Global Business Services (GBS). The Distribution Services segment distributes information technology (IT) products, including IT systems, peripherals, system components, software, networking equipment, consumer electronics, and complementary products in the United States, Canada, Japan, and Mexico. This segment also offers contract assembly services, such as systems design, build-to-order, configure-to-order, and assembly capabilities; value-added services comprising kitting, reconfiguration, asset tagging, and hard drive imaging for government and healthcare sectors; and specialized services in print management, renewals, and networking. The GBS segment offers a range of BPO services, including customer management, renewals management, back of fice processing, and IT outsourcing on a global platform comprising technical support, demand generation, and marketing and administration services through voice, chat, Web, email, digital print, and social media. SYNNEX Corporation also provides logistics services, such as outsourced fulfillment, virtual distribution and direct ship to end-users; financing services consisting of net terms, third party leasing, floor plan financing, letters of credit backed financing, and arrangements; marketing services comprising direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, national and regional trade shows, database analysis, print on demand services, and Web-based marketing; and online and technical support services. The company was formerly known as SYNNEX Information Technologies, Inc. and changed its name to SYNNEX Corporation in October 2003. SYNNEX Corporation was founded in 1980 is headquartered in Fremont, California.

Advisors' Opinion:
  • [By Jayson Derrick]

    After the closing bell on Thursday, SYNNEX (NYSE: SNX) reported its first quarter results. The company announced an EPS of $1.25, beating the consensus estimate of $0.94 million. Revenue of $3.02 billion beat the consensus estimate of $ 2.77 million. Net income for the quarter rose to $38.46 million from $33.391 million in the same quarter last year while operating margin slipped 22 bps year over year to 2.05 percent. Synnex issued guidance and expects its second quarter revenue to be $3.1 billion to $3.2 billion, above the consensus estimate of $3.01 billion. The company is also guided its EPS to be $1.34 to $1.38, above the consensus estimate of $1.14. Shares hit new 52 week highs of $79.44 before closing the day at $76.94, up 23.26 percent.

  • [By Jake L'Ecuyer]

    Equities Trading UP
    SYNNEX (NYSE: SNX) shares shot up 22.86 percent to $76.69 after the company reported better-than-expected fiscal first-quarter results and issued a strong forecast for the fiscal second quarter. For the current quarter, Synnex expected earnings of $1.34 to $1.38 per share on revenue of $3.1 billion to $3.2 billion.

  • [By Lisa Levin]

    Analysts expect SYNNEX (NYSE: SNX) to post its Q2 earnings at $1.36 per share on revenue of $3.17 billion. SYNNEX shares climbed 1.30% to close at $73.80 yesterday.

Top High Tech Stocks To Own For 2014: V.F. Corporation(VFC)

V.F. Corporation designs and manufactures, or sources from independent contractors various apparel and footwear products primarily in the United States and Europe. The company offers apparel, footwear, outdoor gear, skateboard-inspired and surf-inspired footwear, backpacks, luggage, handbags and accessories, outdoor apparel, travel accessories, and women?s active wear primarily under the Vans, The North Face, JanSport, Eastpak, Kipling, Napapijri, Reef, Eagle Creek, and lucy brands; and denim and casual bottoms, and tops principally under Wrangler, Lee, Riders, Rustler, and Timber Creek by Wrangler brands. Its products also include occupational, athletic, and licensed apparel primarily under the Red Kap, Bulwark, Majestic, MLB, NFL, and Harley-Davidson brands; men?s fashion sportswear, denim bottoms, sleepwear, underwear, as well as handbags, luggage, backpacks, and accessories principally under the Nautica and Kipling brands; and denim and casual bottoms, sportswear, acce ssories, men?s apparel and footwear, and women?s sportswear primarily under the 7 For All Mankind, John Varvatos, Splendid, and Ella Moss brands. The company sells its products to specialty stores, department stores, national chains, and mass merchants primarily through its sales force, independent sales agents, and distributors. V.F. Corporation was founded in 1899 and is based in Greensboro, North Carolina.

Advisors' Opinion:
  • [By Mike Deane]

    Before the opening bell on Friday morning, VF Corp (VFC) reported its fourth quarter earnings, posting higher revenues and earnings from last year’s Q4, but still missing analysts’ expectations.

    VFC’s Earnings in Brief

    VFC reported fourth quarter revenues of $3.258 billion, which are up 9% from last year’s Q4 revenues of $3.003 billion. Net income for the quarter came in at $367.7 million, up 10% from the $334 million reported for last year’s Q4. VF Corp reported Q4 EPS of 82 cents, up 9% from the 75 cents reported for last year’s Q4. VFC missed analysts’ EPS estimates of 84 cents, and came in slightly below revenue views of $3.34 billion. Looking ahead to FY2014, VFC sees EPS in the range of $3 to $3.05, which is below analysts’ expectations of $3.09.

    CEO Commentary

    VF’s chairman and CEO, Eric Wiseman, had the following to say about the company’s earnings:���013 was a terrific year for VF with record gross margin and earnings per share. The combined power of our brands and platforms remains our greatest competitive advantage enabling us to push the envelope on product innovation to connect even more intensely with consumers and providing stellar returns to our shareholders.”

    VFC Declares Dividend

    VF Corp declared its quarterly dividend of 26.25 cents, which is payable on March 20, 2014 to all shareholders on record as of March 10.

    Stock Performance

    VFC stock was down $3.59, or 5.99%, in pre-market trading. YTD, the company’s stock is down 3.99%.

  • [By Ben Levisohn]

    At least that’s what was suggested in an article in Bloomberg today, which noted that VFC (VFC), among others, could be interested in buying Lululemon. Sterne Agee’s Sam Poser and Ben Shamsian aren’t buying it:

  • [By Monica Gerson]

    V.F. Corp (NYSE: VFC) is projected to report its Q3 earnings at $3.78 per share on revenue of $3.34 billion.

    Illumina (NASDAQ: ILMN) is estimated to report its Q3 earnings at $0.40 per share on revenue of $342.48 billion.

Top High Tech Stocks To Own For 2014: Guggenheim Multi-Asset Income ETF (CVY)

The Guggenheim Multi-Asset Income ETF (the Fund), formerly Claymore/Zacks Multi-Asset Income Index ETF, seeks investment results that correspond generally to the performance of an equity index called the Zacks Multi-Asset Income Index (the Index). The Index consists of approximately 125 to 150 securities selected, based on investment and other criteria, from a universe of domestic and international companies. The universe of securities within the Index includes United States-listed common stocks, American depositary receipts (ADRs) paying dividends, real estate investment trusts, master limited partnerships, closed-end funds and traditional preferred stocks. The companies in the universe are selected using a methodology developed by the index provider, Zacks Investment Research, Inc. The Fund, using a passive or indexing investment approach, seeks to replicate the performance of the Index. The Fund�� investment advisor is Claymore Advisors, LLC. Advisors' Opinion:
  • [By Genia Turanova]

    Moreover, investors can do one-stop shopping for most income classes through a single ETF as well. One interesting choice here is Guggenheim Multi-Asset Income (CVY).

No comments:

Post a Comment